Production (Stage)
Pangenomic Health Inc.
NARA
CNSX
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 1.70K | 900.00 | 21.70K | 10.20K | 20.80K |
| Total Receivables | 21.70K | 21.50K | 23.20K | 32.10K | 32.40K |
| Inventory | -- | -- | -- | -- | -- |
| Prepaid Expenses | -- | 3.50K | -- | -- | 2.20K |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | -- | -- | -- | -- | -- |
| Total Current Assets | 23.40K | 25.80K | 44.90K | 42.20K | 55.40K |
|
|
|||||
| Total Current Assets | 23.40K | 25.80K | 44.90K | 42.20K | 55.40K |
| Net Property, Plant & Equipment | 1.30K | 1.40K | 1.60K | 3.10K | 5.50K |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | -- | -- | -- | -- | -- |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | -- | -- | -- | -- | -- |
| Total Assets | 24.70K | 27.20K | 46.50K | 45.30K | 60.80K |
|
|
|||||
| Total Accounts Payable | 706.80K | 792.20K | 630.80K | 617.70K | 553.80K |
| Total Accrued Expenses | -- | -- | -- | 351.10K | -- |
| Short-term Debt | -- | -- | -- | -- | 712.50K |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Liabilities | 664.90K | 906.80K | 633.20K | 157.20K | 511.20K |
| Total Other Current Liabilities | 664.90K | 906.80K | 633.20K | 157.20K | 511.20K |
| Total Current Liabilities | 1.37M | 1.70M | 1.26M | 1.13M | 1.78M |
|
|
|||||
| Total Current Liabilities | 1.37M | 1.70M | 1.26M | 1.13M | 1.78M |
| Long-Term Debt | -- | -- | -- | -- | -- |
| Short-term Debt | -- | -- | -- | -- | 712.50K |
| Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | -- | -- | -- | -- | -- |
| Total Liabilities | 1.37M | 1.70M | 1.26M | 1.13M | 1.78M |
|
|
|||||
| Common Stock & APIC | 10.41M | 9.88M | 10.52M | 10.39M | 8.91M |
| Retained Earnings | -15.42M | -15.12M | -15.48M | -15.14M | -13.42M |
| Treasury Stock & Other | 3.66M | 3.57M | 3.73M | 3.67M | 2.79M |
| Total Common Equity | -1.35M | -1.67M | -1.22M | -1.08M | -1.72M |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | -1.35M | -1.67M | -1.22M | -1.08M | -1.72M |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | -1.35M | -1.67M | -1.22M | -1.08M | -1.72M |
|
|
|||||